Methods: Patients (N=54, mean age 36.3±10.9 years [ranged from 22-74 years], 96% African-American, 57% female) recruited between March-December 2015 completed PAINReportIt, a computerized pain measure, demographic questions, the Perceived Discrimination Questionnaire, the Perceived Stress Questionnaire, and the PROMIS measures (anger, anxiety, and depression). We analyzed the data using the statistical software R.
1.5, n=26) p Value Perceived Stress (0-1) 0.30 (0.18) 0.45 (0.15) .001 Anger (10-90) 46.4 (13.2) 56.1 (9.3) .003 Anxiety (10-90) 49.1 (10.3) 57.0 (5.5) <.001 Depression (10-90) 47.4 (10.0) 56.2 (8.0) <.001 Pain Intensity (0-10) 3.6 (2.3) 4.4 (2.3) .24 Fatigue (10-90) 53.8 (11.2) 59.4 (6.0) .03 " align="left" height="146" hspace="12" vspace="5" width="512">Results: We found the mean scores for the study variables to be: Perceived discrimination (1.8±0.7); perceived stress (0.37±0.18); anger (51.1±12.4); anxiety (52.9±9.1); depression (51.6±10.0); average pain intensity (4.5±2.4); and fatigue (56.5±9.4). As shown in the Table, our comparative analysis results indicated that there were statistically significant differences between Low Perceived Discrimination (<=1.5, n=28) and High Perceived Discrimination (>1.5, n=26) groups on study variables, except for the average pain intensity.
|
Conclusions: Findings provide preliminary evidence of the relationship between perceived discrimination, and perceived stress, anger, anxiety, depression, and fatigue in patients with SCD. Findings are consistent with the MPU and suggest that perceived stress related to the experience of perceived discrimination could be the mechanism through which perceived discrimination affects emotional/psychological and physical symptoms in patients with SCD. Results from future studies in this population will provide additional evidence to better understand the influence of perceived discrimination on emotional/psychological and physical symptoms in patients with SCD, and would likely inform future psychoeducational intervention studies to decrease perceived stress, anger, anxiety, depression, and fatigue in patients with SCD who experience perceived discrimination related to their disease or minority status.